Trials / Completed
CompletedNCT00141414
To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.
Pregabablin Open-Label, Follow-On Safety Trial In Patients With Refractory Partial Epilepsy.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 82 (planned)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the long-term safety of pregabalin in refractory partial epilepsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin |
Timeline
- Start date
- 1997-11-01
- Completion
- 2005-10-01
- First posted
- 2005-09-01
- Last updated
- 2007-01-01
Locations
25 sites across 2 countries: United States, Germany
Source: ClinicalTrials.gov record NCT00141414. Inclusion in this directory is not an endorsement.